DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Flomoxef
Flomoxef
Antimicrobial Resistance Benchmark 2020 Antimicrobial Resistance Benchmark 2020
)&F1y3x PHARMACEUTICAL APPENDIX to THE
Yungjin-Pharm-Co-Ltd-Party-Content
Consideration of Antibacterial Medicines As Part Of
In Vitro Activity of Flomoxef Against Extended-Spectrum Β-Lactamase
WO 2011/089216 Al
Evaluation of Short-Time Method with Tetrazolium Salt and Electron
Synergy of Fosfomycin with Other Antibiotics for Gram-Positive and Gram-Negative Bacteria Antonia C
BMC Infectious Diseases 2012, 12:206
United States Patent 19 11 Patent Number: 5,763,603 Trickes 45 Date of Patent: Jun
The New Fifth-Generation Cephalosporins – a Balance Between Safety and Efficacy
Antimicrobial Composition
Summary of the Systematic Review on Surgical Antibiotic Prophylaxis
Statistical Analysis Plan / Data Specifications the Risk of Acute Liver Injury Associated with the Use of Antibiotics. a Replica
In Vitro Efficacy of Flomoxef Against Extended-Spectrum Beta
Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
6-Veterinary-Medicinal-Products-Criteria-Designation-Antimicrobials-Be-Reserved-Treatment
Antibiotic Prophylaxis in Spine Surgery | NASS Clinical Guidelines 1 G Evidence-Based Clinical Guidelines for Multidisciplinary Ethodolo
Top View
Review Antibiotic Discovery: Where Have We Come From, Where Do We Go?
Antibiotic Resistance Gene Resource and Assay List
3-Lactam Antibiotics in Escherichia Coli
Cefazolin Versus Anti-Staphylococcal Penicillins for Treatment of Methicillin-Susceptible Staphylococcus Aureus Bacteremia: a Narrative Review
Prevalence and Clinical Characteristics of Antibiotics Associated Drug Induced Liver Injury
A Milestone in the Fight Against Neonatal Sepsis
An Outbreak of Food Poisoning Caused by an Enteropathogenic
Company Report Cards
Surveillance of Antimicrobial Susceptibility of Enterobacteriaceae Pathogens Isolated from Intensive Care Units and Surgical Units in Russia
Cross-Reactivity in &Beta
Emergence and Prevention Measures for Multidrug Resistant Pseudomonas Aeruginosa in Catheter-Associated Urinary Tract Infection in Spinal Cord Injury Patients
Treatment of ESBL-Producing Klebsiella Pneumoniae Bacteraemia with Carbapenems Or Flomoxef: a Retrospective Study and Laboratory Analysis of the Isolates
Antimicrobial Resistance in Shiga Toxin-Producing Escherichia Coli O157 and O26 Isolates from Beef Cattle
ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
Title Multicenter Retrospective Study of Cefmetazole and Flomoxef
Screening Extended-Spectrum Β-Lactamase Production In
Carbapenem-Sparing Strategies for ESBL Producers: When and How
Surveillance of Healthcare-Associated Infections and Prevention Indicators in European Intensive Care Units HAI-Net ICU Protocol, Version 2.2
Antimicrobial Resistance: Shionogi Advocates Policy Change to Address the Public Health Threat
Critically Important Antimicrobials for Human Medicine, 6Th Revision
Pharmaceutical Appendix to the Tariff Schedule 2
Relation Between Flomoxef Minimum Inhibitory Concentrations and Clinical Outcomes of Patients Treated with Flomoxef for Enterobacteriaceae Bacteremia
Critically Important Antimicrobials for Human Medicine
MAXIMIZING OUR STRENGTHS the Company Policy of Shionogi
NG198 Evidence Review F2
Clinical Experiences of the Infections Caused by Extended-Spectrum Β
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug‑Resistant Bacteria
Flomoxef Sodium PRODUCT DATA SHEET Issue Date 01/06/2020
Melioidosis: an Emerging Infection in Taiwan?
Cefazolin Versus Anti-Staphylococcal Penicillins for Treatment Of
Antibiotic Resistance a Threat to Global Health and Development